FDA Adds Boxed Warning to Merck’s Asthma Drug Singulair About Suicide, Neuropsychiatric Side Effects
In 2008, the FDA issued a warning advising that it would investigate a possible risk of suicide associated with Merck & Co.’s asthma and allergy drug Singulair after there were many reports of increases in agitation, aggression, anxiety, depression and suicidal thoughts. Hallucinations also were documented for children and adolescents taking Singulair. When the drug’s […]
